Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome

Our aim was to determine the incidence of prediabetes and risk of developing cardiovascular disease (CVD) in women with polycystic ovary syndrome (PCOS). This prospective, observational study included 148 women with PCOS, without Type 2 diabetes mellitus (T2DM) and CVD present at baseline. In the f...

Full description

Bibliographic Details
Main Authors: Zelija Velija-Asimi, Azra Burekovic, Tanja Dujic, Amela Dizdarevic-Bostandzic, Sabina Semiz
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2016-11-01
Series:Bosnian Journal of Basic Medical Sciences
Subjects:
Online Access:https://bjbms.org/ojs/index.php/bjbms/article/view/1428
id doaj-6f9b320a73a24c25ba95771fb7445d65
record_format Article
spelling doaj-6f9b320a73a24c25ba95771fb7445d652020-11-24T21:34:05ZengAssociation of Basic Medical Sciences of Federation of Bosnia and HerzegovinaBosnian Journal of Basic Medical Sciences1512-86011840-48122016-11-0116410.17305/bjbms.2016.1428128Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndromeZelija Velija-Asimi0Azra Burekovic1Tanja Dujic2Amela Dizdarevic-Bostandzic3Sabina Semiz4Department of Nuclear Medicine and Endocrinology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and HerzegovinaDepartment of Nuclear Medicine and Endocrinology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and HerzegovinaDepartment of Biochemistry and Clinical Analysis, Faculty of Pharmacy, University of Sarajevo, Sarajevo, Bosnia and HerzegovinaDepartment of Nuclear Medicine and Endocrinology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and HerzegovinaNatural Sciences Department, Faculty of Engineering and Natural Sciences, International University of Sarajevo, Sarajevo, Bosnia and Herzegovina Our aim was to determine the incidence of prediabetes and risk of developing cardiovascular disease (CVD) in women with polycystic ovary syndrome (PCOS). This prospective, observational study included 148 women with PCOS, without Type 2 diabetes mellitus (T2DM) and CVD present at baseline. In the fasting blood samples, we measured lipids, glucose, and insulin levels during oral glucose tolerance test, levels of C-reactive protein (CRP), steroids, 25-hydroxyvitamin D (25-OHD), prolactin, thyroid-stimulating hormone, and parathyroid hormone. The follow-up period was 3 years. At baseline, prevalent prediabetes was present in 18 (12%) of PCOS cases and it progressed to T2DM in 5 (3%) of the cases. Incident prediabetes during the follow-up was noted in 47 (32%) women or 4.7 per 1000 persons/year. Prediabetes was associated with elevated body mass index (BMI) (odds ratio [OR] = 1.089, confidence interval [CI]: 1.010; 1.174, p = 0.026), high baseline levels of CRP (OR = 3.286, CI: 1.299; 8.312, p = 0.012), homeostatic model assessment - insulin resistance (IR) (OR = 2.628, CI: 1.535; 4.498, p < 0.001), and high lipid accumulation product (LAP) (OR = 1.009, CI: 1.003; 1.016, p = 0.005). Furthermore, prediabetes was associated with low 25-OHD (OR = 0.795, CI: 0.724; 0.880, p ≤ 0.05). In addition, cardiovascular risk in PCOS women with prediabetes was high (hazard ratio = 1.092, CI: 1.036; 1.128, p < 0.001). We showed association of prediabetes with high BMI, IR, markers of inflammation, LAP, and low serum 25-OHD concentration. IR appears to be more relevant than the other predictors of prediabetes risk in this study. PCOS women are considered as a high-risk population for prediabetes. https://bjbms.org/ojs/index.php/bjbms/article/view/1428Prediabetes incidencecardiovascular diseasepolycystic ovary syndrome
collection DOAJ
language English
format Article
sources DOAJ
author Zelija Velija-Asimi
Azra Burekovic
Tanja Dujic
Amela Dizdarevic-Bostandzic
Sabina Semiz
spellingShingle Zelija Velija-Asimi
Azra Burekovic
Tanja Dujic
Amela Dizdarevic-Bostandzic
Sabina Semiz
Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome
Bosnian Journal of Basic Medical Sciences
Prediabetes incidence
cardiovascular disease
polycystic ovary syndrome
author_facet Zelija Velija-Asimi
Azra Burekovic
Tanja Dujic
Amela Dizdarevic-Bostandzic
Sabina Semiz
author_sort Zelija Velija-Asimi
title Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome
title_short Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome
title_full Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome
title_fullStr Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome
title_full_unstemmed Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome
title_sort incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome
publisher Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
series Bosnian Journal of Basic Medical Sciences
issn 1512-8601
1840-4812
publishDate 2016-11-01
description Our aim was to determine the incidence of prediabetes and risk of developing cardiovascular disease (CVD) in women with polycystic ovary syndrome (PCOS). This prospective, observational study included 148 women with PCOS, without Type 2 diabetes mellitus (T2DM) and CVD present at baseline. In the fasting blood samples, we measured lipids, glucose, and insulin levels during oral glucose tolerance test, levels of C-reactive protein (CRP), steroids, 25-hydroxyvitamin D (25-OHD), prolactin, thyroid-stimulating hormone, and parathyroid hormone. The follow-up period was 3 years. At baseline, prevalent prediabetes was present in 18 (12%) of PCOS cases and it progressed to T2DM in 5 (3%) of the cases. Incident prediabetes during the follow-up was noted in 47 (32%) women or 4.7 per 1000 persons/year. Prediabetes was associated with elevated body mass index (BMI) (odds ratio [OR] = 1.089, confidence interval [CI]: 1.010; 1.174, p = 0.026), high baseline levels of CRP (OR = 3.286, CI: 1.299; 8.312, p = 0.012), homeostatic model assessment - insulin resistance (IR) (OR = 2.628, CI: 1.535; 4.498, p < 0.001), and high lipid accumulation product (LAP) (OR = 1.009, CI: 1.003; 1.016, p = 0.005). Furthermore, prediabetes was associated with low 25-OHD (OR = 0.795, CI: 0.724; 0.880, p ≤ 0.05). In addition, cardiovascular risk in PCOS women with prediabetes was high (hazard ratio = 1.092, CI: 1.036; 1.128, p < 0.001). We showed association of prediabetes with high BMI, IR, markers of inflammation, LAP, and low serum 25-OHD concentration. IR appears to be more relevant than the other predictors of prediabetes risk in this study. PCOS women are considered as a high-risk population for prediabetes.
topic Prediabetes incidence
cardiovascular disease
polycystic ovary syndrome
url https://bjbms.org/ojs/index.php/bjbms/article/view/1428
work_keys_str_mv AT zelijavelijaasimi incidenceofprediabetesandriskofdevelopingcardiovasculardiseaseinwomenwithpolycysticovarysyndrome
AT azraburekovic incidenceofprediabetesandriskofdevelopingcardiovasculardiseaseinwomenwithpolycysticovarysyndrome
AT tanjadujic incidenceofprediabetesandriskofdevelopingcardiovasculardiseaseinwomenwithpolycysticovarysyndrome
AT ameladizdarevicbostandzic incidenceofprediabetesandriskofdevelopingcardiovasculardiseaseinwomenwithpolycysticovarysyndrome
AT sabinasemiz incidenceofprediabetesandriskofdevelopingcardiovasculardiseaseinwomenwithpolycysticovarysyndrome
_version_ 1725950561895841792